Dengue in the French West-Indies;Aspects récents de la dengue dans les départements français d'Amérique

Virologie

Volumn 12, Issue 3, 2008, Pages 151-157

  Cesaire R ^a   Cabie A ^a   Djossou, F ^b   Lamaury, I ^c   Beaucaire, G ^c   Thomas, L ^a   Hatchuel, Y ^a   Najioullah, F ^a   Yebakima, A ^d   Cardoso, T ^e   Quenel, P ^e   Dussart, P ^f  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^b Centre Hospitalier de Cayenne   (France)

^c Ctr Hosp Univ de Pointe a Pitre   (Guadeloupe)

^d Centre de Démoustication   (Martinique)

^e Cellule Interrégionale d'Épidémiologie Antilles Guyane ^*  (France)

^f Centre National de Reference des Arbovirus Cayenne   (French Guiana)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE; DENGUE VIRUS; EDITORIAL; GENOTYPE; HEALTH PROGRAM; HUMAN; INCIDENCE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 53049109189     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: 10.1684/vir.2008.0169     Document Type: Editorial

References (16)

1. Bulletins d'alertes et de surveillance Antilles Guyane. http://www.martinique.sante.gouv.fr/documents/accueil/cire/basag2007-9.pdf. 2007.
2. Corriveau R, Philippon B, Yebakima A. La dengue dans les départements français d'Amérique : comment optimiser la lutte contre cette maladie. Paris : IRD Éditions, collection «Expertise collégiale», 2003.
3. Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions : time for a reassessment. Lancet 2006 ; 368 : 170-3.
4. Dussart P, Labeau B, Lagathu G, et al. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol 2006 ; 13 : 1185-9.
5. Dussart P, Lavergne A, Lagathu G, et al. Reemergence of dengue virus type 4, French Antilles and French Guiana, 2004-2005. Emerg Infect Dis 2006 ; 12 : 1748-51.
6. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas : lessons and challenges. J Clin Virol 2003 ; 27 : 1-13.
7. Halstead SB. Dengue. Lancet 2007 ; 370 : 1644-52.
8. Monath TP. Dengue and yellow fever : challenges for the development and use of vaccines. N Engl J Med 2007 ; 357 : 2222-5.
9. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003 ; 9 : 921-7.
10. Navarro-Sanchez E, Altmeyer R, Amara A, et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003 ; 4 : 723-8.
11. Peyrefitte CN, Couissinier-Paris P, Mercier-Perennec V, et al. Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies). J Clin Microbiol 2003 ; 41 : 5195-8.
12. Peyrefitte CN, Pastorino BA, Bessaud M, et al. Dengue type 3 virus, Saint Martin, 2003-2004. Emerg Infect Dis 2005 ; 11 : 757-61.
13. Rigau-Perez JG. Severe dengue : the need for new case definitions. Lancet Infect Dis 2006 ; 6 : 297-302.
14. Thomas L, Verlaeten O, Cabié A, et al. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg 2008 ; 78 : 990-8.
15. Tolou H, Couissinier-Paris P, Mercier V, et al. Complete genomic sequence of a dengue type 2 virus from the French West Indies. Biochem Biophys Res Commun 2000 ; 277 : 89-92.
16. World Health Organization. Dengue haemorrhagic fever : diagnosis, treatment, prevention and control. Geneva : WHO, 1997.